日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of the Safety and Pharmacokinetics of Single-Dose Oral Probenecid Administration in Healthy Dogs

对健康犬单次口服丙磺舒的安全性和药代动力学评价

Cook, Margaret; Gustafson, Daniel L; Kroeker, Katie; Shropshire, Sarah; Zersen, Kristin M

Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

在COXEN联合新辅助化疗治疗肌层浸润性膀胱癌的II期研究中,分子亚型与病理反应、无进展生存期(PFS)和总生存期(OS)的相关性

Lerner, Seth P; McConkey, David J; Tangen, Catherine M; Meeks, Joshua J; Flaig, Thomas W; Hua, Xing; Daneshmand, Siamak; Alva, Ajjai Shivaram; Lucia, M Scott; Theodorescu, Dan; Goldkorn, Amir; Milowsky, Matthew I; Choi, Woonyoung; Bangs, Rick; Gustafson, Daniel L; Plets, Melissa; Thompson, Ian M Jr

Plasma Concentrations of Oral Ondansetron in Hospitalized Dogs Exhibiting Clinical Signs of Nausea

住院犬出现恶心临床症状时口服昂丹司琼的血浆浓度

Zersen, Kristin M; Molli, Angela; Weisbeck, Brooke G; Fedotova, Samantha; Quimby, Jessica M; Gustafson, Daniel L; Shropshire, Sarah B

EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression

EYA2酪氨酸磷酸酶抑制剂可降低MYC表达并阻止髓母细胞瘤进展。

Wolin, Arthur R; Vincent, Melanie Y; Hotz, Taylor; Purdy, Stephen C; Rosenbaum, Sheera R; Hughes, Connor J; Hsu, Jessica Y; Oliphant, Michael U J; Armstrong, Brock; Wessells, Veronica; Varella-Garcia, Marileila; Galbraith, Matthew D; Pierce, Angela; Wang, Dong; Venkataraman, Sujatha; Danis, Etienne; Veo, Bethany; Serkova, Natalie; Espinosa, Joaquin M; Gustafson, Daniel L; Vibhakar, Rajeev; Ford, Heide L

Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma

多中心淋巴瘤犬个体化化疗药物剂量递增

Siewert, Jacob M; Gustafson, Daniel L; Weishaar, Kristen M; Galloway, Annie M; Thamm, Douglas H

The efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: A double-blinded crossover study

大麻二酚作为辅助治疗药物治疗51只犬难治性特发性癫痫的疗效和安全性:一项双盲交叉研究

Rozental, Aaron J; Weisbeck, Brooke G; Corsato Alvarenga, Isabella; Gustafson, Daniel L; Kusick, Breonna R; Rao, Sangeeta; Bartner, Lisa R; McGrath, Stephanie

Pharmacokinetics of escalating single-dose administration of cannabidiol to cats

递增单次剂量大麻二酚给猫给药的药代动力学

Rozental, Aaron J; Gustafson, Daniel L; Kusick, Breonna R; Bartner, Lisa R; Castro, Stephanie Cruz; McGrath, Stephanie

Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695)

新辅助化疗治疗肌层浸润性膀胱癌的 II 期研究的长期结果(SWOG S1314;NCT02177695)

Flaig, Thomas W; Tangen, Catherine M; Daneshmand, Siamak; Alva, Ajjai Shivaram; Lucia, M Scott; McConkey, David James; Theodorescu, Dan; Goldkorn, Amir; Milowsky, Matthew I; Bangs, Rick; MacVicar, Gary R; Bastos, Bruno R; Fowles, Jared S; Gustafson, Daniel L; Plets, Melissa; Thompson, Ian M Jr; Lerner, Seth P

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma

氯沙坦可阻断骨肉瘤诱导的单核细胞募集,并与激酶抑制剂托西拉尼联合使用,在犬转移性骨肉瘤中显示出显著的临床疗效。

Regan, Daniel P; Chow, Lyndah; Das, Sunetra; Haines, Laurel; Palmer, Eric; Kurihara, Jade N; Coy, Jonathan W; Mathias, Alissa; Thamm, Douglas H; Gustafson, Daniel L; Dow, Steven W

Characterizing the molecular and immune landscape of canine bladder cancer

犬膀胱癌的分子和免疫特征分析

Cronise, Kathryn E; Das, Sunetra; Hernandez, Belen G; Regan, Daniel P; Dailey, Deanna D; McGeachan, Robert I; Lana, Susan E; Page, Rodney L; Gustafson, Daniel L; Duval, Dawn L